PCN97 A COST-UTILITY ANALYSIS ON THE USE OF TRASTUZUMAB + ANASTROZOLE COMPARED TO LAPATINIB + LETROZOLE, LETROZOLE MONOTHERAPY OR ANASTROZOLE MONOTHERAPY IN THE TREATMENT OF HER2+/HORMONE RECEPTOR POSITIVE (HR+) METASTATIC BREAST CANCER (MBC) FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)

✍ Scribed by S McNamara; L Moore; J Ray

• Book ID: 118614188
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 76 KB
• Volume: 13
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(11)71993-3